ORIC Pharmaceuticals is being led by Richard Heyman, the serial biopharma entrepreneur behind companies like Aragon Pharmaceuticals, Seragon Pharmaceuticals and Metacrine.
An interesting new San Diego biotech – Metacrine – is in the works. CFO Trisha Millican said the company’s raised $6.85 million, and is aiming for $33 million – but otherwise is keeping silent on its dealings. So time for some extrapolation: It’s anyone’s guess what the target the company’s chasing, but my money’s on a hormone-driven […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.